Daptomycin
- Strength
- 350 mg/7mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Lipopeptide Antibacterial
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Listed by Civica, Inc.
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Lipopeptide Antibacterial |
| Approval route | NDA — original brand approval |
| NDC code | 72572-158 |
| FDA application | NDA217415 |
| RxNorm concept | 403920 |
| Package sizes listed | 1 |
| Marketed since | November 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Mylan Institutional LLC
Not stocked by us — reference only
Hospira, Inc.
Not stocked by us — reference only
Mylan Institutional LLC
Not stocked by us — reference only
Xellia Pharmaceuticals USA LLC
Not stocked by us — reference only
BE Pharmaceuticals Inc.
Not stocked by us — reference only
Xellia Pharmaceuticals USA LLC
Not stocked by us — reference only
Meitheal Pharmaceuticals Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.